Dali Li
Impact in
- Aging top 2%
Papers in
-
- CRISPR and Genetic Engineering 41
- Pluripotent Stem Cells Research 11
- RNA Research and Splicing 10
- Epigenetics and DNA Methylation 9
- RNA modifications and cancer 9
- RNA Interference and Gene Delivery 8
- Genetics 29
- Virus-based gene therapy research 8
- Co-authors
- Mingyao Liu (75 shared papers)Jian Luo (25 shared papers)Yiyun Cheng (3 shared papers)Song Zhang (2 shared papers)Jiangtao Shen (1 shared paper)Liren Wang (24 shared papers)Yanjiao Shao (17 shared papers)Zhengfang Yi (9 shared papers)
- Journals
- Journal of Biological Chemistry (10 papers)Science China Life Sciences (7 papers)Current Molecular Medicine (6 papers)Science Advances (5 papers)Nature Communications (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Dali Li
163 papers receiving 6.1k citations
Dali Li's Hit Papers
Peers
Comparison fields: 5 of 136
- Aging 110
- Business and International Management 123
- Molecular Biology 4.0k
- Cancer Research 638
- Oncology 1.0k
Countries citing papers authored by Dali Li
This map shows the geographic impact of Dali Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dali Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dali Li more than expected).
Fields of papers citing papers by Dali Li
This network shows the impact of papers produced by Dali Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dali Li. The network helps show where Dali Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Dali Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing Hit paper breakdown → | 2020 | 308 |
| 2 | 2016 | 284 | |
| 3 | 2018 | 253 | |
| 4 | 2014 | 155 | |
| 5 | Local hyperthermia therapy induces browning of white fat and treats obesity Hit paper breakdown → | 2022 | 153 |
| 6 | 2009 | 148 | |
| 7 | 2016 | 133 | |
| 8 | CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia Hit paper breakdown → | 2022 | 119 |
| 9 | 2010 | 115 | |
| 10 | 2010 | 115 | |
| 11 | 2008 | 104 | |
| 12 | 2020 | 99 | |
| 13 | 2015 | 99 | |
| 14 | 2009 | 97 | |
| 15 | 2020 | 84 | |
| 16 | 2015 | 84 | |
| 17 | 2013 | 81 | |
| 18 | 2018 | 80 | |
| 19 | 2013 | 78 | |
| 20 | 2015 | 77 |
About Dali Li
Dali Li is a scholar working on Molecular Biology, Genetics, Cancer Research, Oncology and Immunology, having authored 166 papers that have together received 6.2k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (41 papers), Pluripotent Stem Cells Research (11 papers), RNA Research and Splicing (10 papers), Epigenetics and DNA Methylation (9 papers), RNA modifications and cancer (9 papers), Reproductive Biology and Fertility (9 papers), RNA Interference and Gene Delivery (8 papers) and Virus-based gene therapy research (8 papers). The work is most often cited by research in Aging (110 citations), Business and International Management (123 citations), Molecular Biology (4.0k citations), Cancer Research (638 citations) and Oncology (1.0k citations). Dali Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Mingyao Liu, Jian Luo, Yiyun Cheng, Song Zhang, Jiangtao Shen, Liren Wang, Yanjiao Shao, Zhengfang Yi, Sung‐Gook Cho and Shenglan Li. Their work appears in journals such as Journal of Biological Chemistry, Science China Life Sciences, Current Molecular Medicine, Science Advances and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.